Preferred Pharmaceuticals recalls
Preferred Pharmaceuticals appears in 56 official U.S. recall notices indexed by RecallRadar, most recently on 2026-10-14.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 56 |
|---|---|
| Published | 2018-08-29 to 2026-10-14 |
| By agency | FDA Drug (56) |
| By classification | Class II (56) |
| By status | terminated (29), ongoing (27) |
| Distribution named in notices | AL, AZ, CA, CT, FL, GA, IL, IN, KS, NV, OK, SC, US, VA |
Recalls
- Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 6…
FDA Drug · Class II · 2026-10-14 · Preferred Pharmaceuticals
Reason: Failed Content Uniformity Specifications - Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care
FDA Drug · Class II · 2026-04-15 · Preferred Pharmaceuticals
Reason: Lack of Assurance of Sterility - Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals ND…
FDA Drug · Class II · 2025-12-24 · Preferred Pharmaceuticals
Reason: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished prod… - Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03
FDA Drug · Class II · 2025-05-07 · Preferred Pharmaceuticals
Reason: cGMP Deviations - Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, ND…
FDA Drug · Class II · 2024-09-04 · Preferred Pharmaceuticals
Reason: Failed Impurities/Degradation Specifications - at 18-month Stability testing - Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
FDA Drug · Class II · 2024-05-29 · Preferred Pharmaceuticals
Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit - Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-coun…
FDA Drug · Class II · 2023-07-12 · Preferred Pharmaceuticals
Reason: Failed Stability Specifications - Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630…
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9)
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8190-9
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Simvastatin Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9747-9
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. - Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3)
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Simvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9)
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3)
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Simvastatin Tablets, USP, 20 mg, Packaged as: a) 90-count bottle (NDC 68788-9869-9)
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6)
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. - Pravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-82…
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3)
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7328-1
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Glimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8095-9
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595-6), c) 90-count bo…
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. - Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8066-9
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7971-3
FDA Drug · Class II · 2023-04-12 · Preferred Pharmaceuticals
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. - Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc
FDA Drug · Class II · 2023-02-01 · Preferred Pharmaceuticals
Reason: Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet. - Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09
FDA Drug · Class II · 2022-06-01 · Preferred Pharmaceuticals
Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5 mg, Pkg Size: 30, NDC: 68788-7758-03
FDA Drug · Class II · 2022-06-01 · Preferred Pharmaceuticals
Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - Losartan Potassium Tab
FDA Drug · Class II · 2022-05-04 · Preferred Pharmaceuticals
Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits. - Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bottle, Rx Only, Mfg: Sola Pharmaceutical, Preferred Pharmaceutic…
FDA Drug · Class II · 2022-04-27 · Preferred Pharmaceuticals
Reason: CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program. - Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent Pharma, Inc., PREFERRED Pharmaceuticals, In…
FDA Drug · Class II · 2022-04-20 · Preferred Pharmaceuticals
Reason: CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program. - Econazole Nitrate Cream, 1%, Generic for Spectazole, 30 gm tube, Rx Only, Preferred Pharmaceuticals, Inc., The Physican's Solution, Mfg: Te…
FDA Drug · Class II · 2022-04-20 · Preferred Pharmaceuticals
Reason: CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program. - Preferred Pharmaceuticals, Inc
FDA Drug · Class II · 2022-04-20 · Preferred Pharmaceuticals
Reason: Out of specification results observed in dissolution during long term stability testing. - Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets per bottle, NDC: 6878…
FDA Drug · Class II · 2022-03-09 · Preferred Pharmaceuticals
Reason: CGMP deviations - Diclofenac Sodium Topical Solution, 1.5% w/w, packaged in 150 mL bottles, Rx only, Mfg: SOLA Pharmaceuticals Preferred Pharmaceuticals, Inc…
FDA Drug · Class II · 2021-12-22 · Preferred Pharmaceuticals
Reason: Defective container: Out of specification for container integrity leading to bottles leaking. - Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab
FDA Drug · Class II · 2021-05-26 · Preferred Pharmaceuticals
Reason: CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day. - Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only, Repackaged by Prefe…
FDA Drug · Class II · 2021-05-05 · Preferred Pharmaceuticals
Reason: Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin - Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc
FDA Drug · Class II · 2020-11-25 · Preferred Pharmaceuticals
Reason: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit. - Nature-Throid, 1.5 Grain, (97.5 mg), (Thyroid U.S.P. 1.5 gr. (97.5mg)/Liothyronine (T3) 13.5mcg/Levothyroxine (T4) 57mcg, 90-count bottles,…
FDA Drug · Class II · 2020-09-30 · Preferred Pharmaceuticals
Reason: CGMP Deviations - Nature-Throid, 1/2 Grain, 32.5 mg (Thyroid U.S.P. 1/2 gr. (32.5 mg)/Liothyronine (T3) 4.5mcg/Levothyroxine (T4) 19mch, 100-count tablets, R…
FDA Drug · Class II · 2020-09-30 · Preferred Pharmaceuticals
Reason: CGMP Deviations - Nature-Throid, 3/4 Grain (48.75 mg) Thyroid U.S.P. 3/4 gr. (48.75 mg)/Liothyronine (T3) 6.75mcg/Levothyroxine (T4) 28.5mcg, 90-count tablet…
FDA Drug · Class II · 2020-09-30 · Preferred Pharmaceuticals
Reason: CGMP Deviations - Nature-Throid, 1 Grain, 65 mg (Thyroid U.S.P. 1 gr. (65mg)/Liothyronine (T3) 9mcg/Levothyroxine (T4) 38mcg, packaged in a) 90-count bottles…
FDA Drug · Class II · 2020-09-30 · Preferred Pharmaceuticals
Reason: CGMP Deviations - Lidothol Patch, Lidocaine 4.5% & Menthol 5%, In each patch: lidocaine 4.5% topical anesthetic, menthol 5% topical analgesic, Pkg Size 15 pa…
FDA Drug · Class II · 2020-07-22 · Preferred Pharmaceuticals
Reason: CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch. - Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc., Farmingdale, NY, Pr…
FDA Drug · Class II · 2020-07-08 · Preferred Pharmaceuticals
Reason: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit. - Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles (NDC: 68788-7388-6…
FDA Drug · Class II · 2020-01-29 · Preferred Pharmaceuticals
Reason: CGMP Deviations: Presence of NDMA impurity detected in product. - Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 687…
FDA Drug · Class II · 2020-01-29 · Preferred Pharmaceuticals
Reason: CGMP Deviations: Presence of NDMA impurity detected in product. - Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06), Mfg: Amneal Pharmace…
FDA Drug · Class II · 2019-12-18 · Preferred Pharmaceuticals
Reason: CGMP Deviations: Presence of NDMA impurity detected in product. - Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg: Taro Pharm
FDA Drug · Class II · 2019-12-04 · Preferred Pharmaceuticals
Reason: Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.